Pancreatic Cancer Research

ResearcherLiaoning Provincial People's HospitalNo recent work listed

Xiang Fei

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer. Co-author DOI 10.1155/2022/7117014↗
  2. HOXB5 promotes proliferation, migration, and invasion of pancreatic cancer cell through the activation of the GSK3β/β-catenin pathway. First author DOI 10.1097/cad.0000000000000948↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingming Kong · 2 shared papers, 2020–2022 · strength 0.33
  2. Xiaodong Tan · 2 shared papers, 2020–2022 · strength 0.33
  3. Peng Liu · 1 shared paper, 2022 · strength 0.16
  4. Yang Gao · 1 shared paper, 2020 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.